RxDoctor Payments Data

Gregory Garner, MD

Family Medicine · Baton Rouge, LANPI 1326215633

Payments from drug & device makers

$806in general payments, 2019–2025

Across 37 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$228
  • Johnson & Johnson$205
  • Merck$96
  • Lilly USA, LLC$88
  • Exact Sciences$76
  • GSK$23
  • plus $92 from 6 others

What the payments were for

  • Food & beverage$78998%
  • Entertainment$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$806 in reported general payments places this provider in the 50th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$1,050
Medicare patients
34
Services billed
64

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide102$101,371
JardianceEmpagliflozin74$90,782
FarxigaDapagliflozin Propanediol18$31,208
LinzessLinaclotide17$14,965
MounjaroTirzepatide11$12,260
Spiriva HandihalerTiotropium Bromide11$11,403
Lantus SolostarInsulin Glargine,hum.Rec.Anlog47$5,791
SymbicortBudesonide/Formoterol Fumarate25$5,503
Insulin Lispro Kwikpen U-100Insulin Lispro16$2,784
Humalog Mix 75-25 KwikpenInsulin Lispro Protamin/Lispro14$2,541
ShingrixVaricella-Zoster Ge/As01b/Pf12$2,190
Atorvastatin Calcium196$1,399
Metoprolol Succinate94$1,266
Amlodipine Besylate212$1,089
Gabapentin49$922

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Symbicort$11$36,71143 claims
Lilly USA, LLCMounjaro$88$12,26011 claims
GSKShingrix$23$2,19012 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →